Increase your chances of passing the CFA Institute CFA-Level-II exam questions on your first try. Practice with our free online CFA-Level-II exam mock test designed to help you prepare effectively and confidently.



Charles Connor, CFA, is a portfolio manager at Apple Investments, LLC . Apple is a U .S .-based firm offering a wide spectrum of investment products and services. Connor manages the Biogene Fund, a domestic equity fund specializing in small capitalization growth stocks. The Biogene Fund generally takes significant positions in stocks, commonly owning 4.5-5% of the outstanding shares. The fund's prospectus limits positions to a maximum of 5% of the shares outstanding. The performance of the Biogene Fund has been superior over the last few years, but for the last two quarters the fund has underperformed its benchmark by a wide margin. Connor is determined to improve his performance numbers going forward.
The Biogene prospectus allows Connor to use derivative instruments in his investment strategy. Connor frequently uses options to hedge his fund's exposure as he builds or liquidates positions in his portfolio since Biogene's large positions often take several weeks to acquire. For example, when he identifies a stock to buy, he often buys call options to gain exposure to the stock. As he buys the stock, he sells off the options or allows them to expire. Connor has noticed that the increased volume in the call options often drives the stock price higher for a few days. He has seen a similar negative effect on stock prices when he buys large amounts of put options.
The end of the quarter is just a few days away, and Connor is considering three transactions:
Transaction A: Buying Put Options on Stock A
The Biogene Fund owns 4,9% of the outstanding stock of Company A, but Connor believes the stock is fully valued and plans to sell the entire position. He anticipates that it will take approximately 45 trading days to liquidate the entire Biogene position in Stock A
The Biogene Fund owns 5% of the outstanding stock of Company B . Connor believes there is significant appreciation potential for Stock B, but the stock price has dropped in recent weeks. Connor is hoping that by taking an option position, there will be a carryover effect on ihe stock price before quarter end.
Transaction C: Selling the Biogene Fund's Entire Position in .Stock C
Connor believes that Stock C is still attractive, but he is selling the stock with the idea that he will repurchase the position next month. The motivation for the transaction is to capture a capital loss that will reduce the Biogene Fund's tax expense for the year.
Apple has an investment banking department that is active in initial public offerings (IPOs). George Arnold, CFA, is the senior manager of the IPO department. Arnold approached Connor about Stock D, a new IPO being offered by Apple. Stock D will open trading in two days. Apple had offered the IPO to all of its clients, but approximately 20% of the deal remained unsold. Having read the prospectus, Connor thinks Stock D would be a good fit for his fund, and he expects Stock D to improve his performance in both the short and long term. Connor is not aware of any information related to Stock D beyond that provided in the prospectus. Connor asked to purchase 5% of the IPO, but Arnold limited Biogene's share to 2%, explaining:
'With Biogene's reputation, any participation will make the unsold shares highly marketable. Further, we may need Biogene to acquire more Stock D shares at a later date if the price does not hold up.'
Connor is disappointed in being limited to 2% of the offering and suggests to Arnold in an e-mail that, given the 2% limitation, Biogene will not participate in the IPO . Arnold responded a few hours later with the following message:
'I have just spoken with Ms. D, the CFO of Stock D . Although it is too late to alter the prospectus, management believes they will receive a large contract from a foreign government that will boost next year's sales by 20% or more. I urge you to accept the 2%---you won't be sorry!'
After reviewing Arnold's e-mail, Connor agrees to the 2% offer.
Based upon Connor's acceptance of the 2% limitation after receiving the e-mail from Arnold:
Valentine notes that a share of Trailblazer's stock is currently priced at $32. Moreover, she expects the dividend for next year to be $1.47 and forecasts that the price of one share of Trailblazer stock at the end of the year wilt be $35.
In her report, Valentine makes the following statements about Trailblazer dividends:
Statement 1: Trailblazer is expected to pay a dividend next year and will continue to do so for the foreseeable future.
Statement 2: The required rate of return for Trailblazer stock will likely exceed the growth rate of its dividends.
Statement 3: Trailblazer is in a mature sector of its industry, and accordingly,
I expect dividends to decline to a constant rate of 4% indefinitely.
In speaking to a colleague at her firm, Valentine makes the following additional statements after her report is released:
Statement 4: Trailblazer has a 10-year history of paying regular quarterly dividends.
Statement 5: Over a recent 10-year period, Trailblazer has experienced one 3-year period of consecutive losses and another period of two annual losses in a row but has been extremely profitable in the remaining five years.
Valentine is concerned about the theoretical validity of using the APT to obtain an estimate of the required rate of return on equity. She decides to attend a conference dealing specifically with estimation techniques that analysts can employ. At one of the conference seminars, the following points are made:
Statement 6: The APT is a better approach than the CAPM because even though the factor risk premiums are difficult to estimate, the CAPM is more problematic because it relies on a single market risk premium estimate, which in turn leads to greater input uncertainty.
Statement 7: Model uncertainty is a problem with the APT but not with the CAPM.
Valentine is also analyzing the stock of Farwell, Inc. Farwell shares are currently trading at $48 based on current earnings of $4 and a current dividend of $2.60. Dividends are expected to grow at 5% per year indefinitely. The risk-free rate is 3.5%, the market risk premium is 4.5%, and Farwell's beta is estimated to be 1.2.
Are Statements 6 and 7 correct?
© Copyrights FreeMockExams 2026. All Rights Reserved
We use cookies to ensure that we give you the best experience on our website (FreeMockExams). If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the FreeMockExams.